The diagnostic value of transbronchial lung cryobiopsy combined with rapid on-site evaluation in diffuse lung diseases: a prospective and self-controlled study
- PMID: 35366837
- PMCID: PMC8977016
- DOI: 10.1186/s12890-022-01898-z
The diagnostic value of transbronchial lung cryobiopsy combined with rapid on-site evaluation in diffuse lung diseases: a prospective and self-controlled study
Erratum in
-
Correction to: The diagnostic value of transbronchial lung cryobiopsy combined with rapid on-site evaluation in diffuse lung diseases: a prospective and self-controlled study.BMC Pulm Med. 2022 Apr 20;22(1):150. doi: 10.1186/s12890-022-01946-8. BMC Pulm Med. 2022. PMID: 35443658 Free PMC article. No abstract available.
Abstract
Background: The etiology of interstitial lung diseases (ILDs) is varied. Early diagnosis and a specific pathological type could significantly improve the prognosis. Mostly, it is difficult to make the etiology diagnosis of ILD through traditional biopsy methods. It will be of great significance to explore an effective biopsy method.
Methods: The prospective study was designed to evaluate the diagnostic value of transbronchial lung cryobiopsy (TBCB) combined with rapid on-site evaluation (ROSE), compared with conventional transbronchial lung biopsy (TBLB), in a large sample of ILD patients. All patients enrolled will undergo both TBLB and TBCB procedures. The study will observe the differences in the diagnostic efficiency of pathological typing and incidence of operation-related complications between TBCB and TBLB. Besides, it will analyze the relationship between the time of biopsy and the incidence of complications, the relationship between freezing time, size of specimen, and complications. And it will evaluate the consistency of pathological, clinical, and radiology.
Discussion: It may be the first time that ROSE technique will be used in the diagnosis of ILD. The results of this study will clarify the value of TBCB in the diagnosis of ILD and confirm its safety and effectiveness, which is expected to significantly improve the efficiency of diagnosis in ILD patients.
Trail registration: The trial was registered on the Chinese Clinical Trial Registry website ( http://www.chictr.org.cn/showproj.aspx?proj=57834 ) (Registration number: ChiCTR2000035492).
Keywords: Complication; Diagnosis; Interstitial lung disease (ILD); Rapid on-site evaluation (ROSE); Transbronchial lung biopsy (TBLB); Transbronchial lung cryobiopsy (TBCB).
© 2022. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
[The efficacy and safety of transbronchial lung cryobiopsy in interstitial lung disease: a prospective study].Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jun 12;41(6):467-471. doi: 10.3760/cma.j.issn.1001-0939.2018.06.007. Zhonghua Jie He He Hu Xi Za Zhi. 2018. PMID: 29886621 Chinese.
-
Transbronchial biopsy results according to diffuse interstitial lung disease classification. Cryobiopsy versus forceps: MULTICRIO study.PLoS One. 2020 Sep 21;15(9):e0239114. doi: 10.1371/journal.pone.0239114. eCollection 2020. PLoS One. 2020. PMID: 32956379 Free PMC article. Clinical Trial.
-
[Transbronchial lung cryobiopsy in diffuse lung disease: a pathological analysis of 173 cases].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):228-233. doi: 10.3760/cma.j.issn.1001-0939.2020.03.018. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32164094 Chinese.
-
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.Respiration. 2018;95(3):188-200. doi: 10.1159/000484055. Epub 2018 Jan 9. Respiration. 2018. PMID: 29316560
-
Transbronchial Cryobiopsy Versus Transbronchial Forceps Biopsy for Acute Cellular Rejection Detection in Lung Transplantation: A Meta-Analysis.Arch Bronconeumol. 2024 Nov;60(11):698-704. doi: 10.1016/j.arbres.2024.06.006. Epub 2024 Jun 18. Arch Bronconeumol. 2024. PMID: 38945699 English, Spanish.
Cited by
-
Rapid On-Site Evaluation Performed by an Interventional Pulmonologist: A Single-Center Experience.J Pers Med. 2024 Jul 18;14(7):764. doi: 10.3390/jpm14070764. J Pers Med. 2024. PMID: 39064018 Free PMC article.
-
Correction to: The diagnostic value of transbronchial lung cryobiopsy combined with rapid on-site evaluation in diffuse lung diseases: a prospective and self-controlled study.BMC Pulm Med. 2022 Apr 20;22(1):150. doi: 10.1186/s12890-022-01946-8. BMC Pulm Med. 2022. PMID: 35443658 Free PMC article. No abstract available.
References
-
- American Thoracic S, European Respiratory S, American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277–304. doi: 10.1164/ajrccm.165.2.ats01. - DOI - PubMed
-
- Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society (vol 63, Suppl V, pg v1, 2008). Thorax. 2008; 63:1029. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous